{"nct_id":"NCT05601752","title":"ADP-A2M4CD8 Monotherapy and in Combination with Nivolumab in HLA-A2+ Subjects with MAGE-A4 Positive Ovarian Cancer (SURPASS-3)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-12","start_date":"2023-06-26","start_date_type":"ACTUAL","primary_completion_date":"2026-08-12","primary_completion_date_type":"ESTIMATED","completion_date":"2026-08-12","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ADAP"]}